New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...

A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...

“They suspected lung cancer,” said lung cancer awareness advocate Matthew Koebbe. “We did a biopsy, and confirmed that, yes, ...

Joshua Ray Walker let fans know this week that Thursday is slated to be a big day for him in his battle against cancer. The ...

The FDA has approved Rybrevant plus chemotherapy in certain patients with locally advanced or metastatic non-small cell lung ...

Treatment of non-small cell lung cancer (NSCLC) depends on the stage you're in and can include chemotherapy, surgery, ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

A triple-whammy of advanced new diagnostic and treatment options holds the promise for better outcomes for New Jersey lung ...

The LUNG FORCE Run/Walk provides critical funds for lifesaving lung cancer research, early detection initiatives and ...